Ackermans & van Haaren
Overview
Ackermans & van Haaren is a Belgian diversified investment firm that makes long-term investments in companies across sectors including marine engineering, private banking, real estate, and energy.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Medikabazaar | Feb 2024 | Early Funding | Co-investor |
| AstriVax | Aug 2022 | Seed | Co-investor |
| OncoDNA | Jul 2023 | Series C | Co-investor |
| DISCO Pharmaceuticals | Dec 2025 | Seed | Lead |
| Indigo Diabetes N.V. | Jul 2020 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Sonali Chandmal
Board of Directors
Bénedith Oben
Associate Investment Manager - Life Sciences
Giacomo Stefani
Investment Manager
Jeroen Vangindertael
Investment Manager
Lenny Van Steenhuyse
Investment Manager
Thijs Hoste
Investment Manager Group Controller
Vishal Prasad
Associate Investment Manager
Chris Van Raemdonck
Communication & Investor Relations
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ackermans & van Haaren based?
Ackermans & van Haaren is headquartered in Antwerp, United States.
When was Ackermans & van Haaren founded?
Ackermans & van Haaren was founded in 1876.
How many portfolio companies does Ackermans & van Haaren have?
Ackermans & van Haaren has 15 portfolio companies in Caplight's dataset.
What are some companies in Ackermans & van Haaren's portfolio?
Portfolio companies visible on Caplight include Medikabazaar, AstriVax, OncoDNA, DISCO Pharmaceuticals, Indigo Diabetes N.V..
What was Ackermans & van Haaren's most recent investment shown here?
Ackermans & van Haaren's most recent investment in this portfolio sample was in DISCO Pharmaceuticals in 2025.
What sectors does Ackermans & van Haaren focus on?
Ackermans & van Haaren focuses on Healthcare & Life Sciences, Media, Entertainment & Gaming, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Ackermans & van Haaren focus on?
Ackermans & van Haaren typically invests at the MultiStage stage.
What is Ackermans & van Haaren's AUM?
Ackermans & van Haaren's assets under management are estimated between $5.8B and $5.8B.